Surge in atrial fibrillation is expected to boost the growth of cardiac ablation devices market. Market is driven by high prevalence of cardiac diseases, upsurge in investment in research & development, improvement in healthcare sector/infrastructure.
Moreover, high acceptance of catheter ablation & recent developments introducing robotic catheter navigation systems are offering attractive opportunities for the growth of the market.
In addition to this, high rate of geriatric population in countries such as US, regions in Europe, and Japan is leading to the rise in cardiac diseases. Moreover, enhanced health care infrastructure, advancement in healthcare facilities has improved in recent years. Moreover, better access to various advanced diagnostic and treatment services is expected to boost the growth of the market during forecast period.
Download Free Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=4426
Besides this, North America is expected to offer various attractive opportunities as the market consists of leading players such as Johnson & Johnson, Boston Scientific Corporation, Abbott. Moreover, effective product positioning and various advancements in technology are helping these big firms to generate maximum revenues in the region.
Key Takeaways:
North America is expected to witness the maximum share of around 37% of the global cardiac ablation technologies market. As per various studies, cardiac arrest is the leading cause of deaths in the US. This offers opportunities for the key cardiac ablation technologies in the region.
Asia Pacific is expected to grow at a rapid pace during forecast period due to increasing cases of atrial fibrillation & significant investments in healthcare across the region.
By Technology type, radiofrequency is expected to dominate the market and occupy a revenue share of around 55% by 2032. In meanwhile, cryoablation is gaining huge traction due to successful trials of cryoablation done on patients suffering from breast cancer in the US, European countries and Japan.
By application area, atrial fibrillation is expected to dominate the market
Growth Drivers:
Rapid approvals by Food and Drug Administration has boosted the growth of the market
Increasing incidences and prevalence of cancer and cardiac conditions, technological advancements in ablation products and technologies is likely to boost the growth during forecast period.
Rise in geriatric population in expected to contribute to the market growth. As per World Health Organization, number of people aged 65 years and above is expected to reach 1.5 Billion by 2050.
Advancements in technologies such as multi-electrode ablation catheters, balloon-mounted technologies are expected to act as a boon for the growth of cardiac ablation technology market.
Restraints:
During the peak of Covid-19 pandemic, growth of cardiac ablation treatments were curtailed to conserve healthcare resources and limit exposure.
Share Your Requirements & Get Customized Reports: https://www.factmr.com/connectus/sample?flag=RC&rep_id=4426
Competitive Landscape:
Key players in the market are adopting innovative strategies such as marketing tactics, technological advancements, mergers and acquisitions to expand their market share in the market.
In 2022, Arga Medtech, a company focusing on Coherent Sine-Burst Electroporation, non-thermal cardiac ablation system for treating cardiac arrhythmias, presented its preliminary findings for its innovative technology in San Franscisco.
In 2021, Boston Scientific entered into an agreement with Baylis Medical Company to acquire the company. This acquisition will help expand electrophysiology and heart product portfolio
Key Companies Profiled by Fact.MR
- Boston Scientific Corporation
- Biosense Webster Inc.
- Johnson & Johnson
- Medtronic Plc.
- MicroPort Scientific Corporation
- CardioFocus Inc.
- Jude Medical, Inc. (Abbott)
- Stryker Corporation
Segmentation of Cardiac Ablation Technologies Industry Research
By Technology Type :
- Radiofrequency Cardiac Ablation
- Ultrasound Cardiac Ablation
- Cryoablation Cardiac Ablation
- Microwave Cardiac Ablation
- Laser Cardiac Ablation
- Other Cardiac Ablation Technologies
By Application :
- Cardiac Ablation for Atrial Fibrillation
- Cardiac Ablation for Ventricular Tachycardia
- Cardiac Ablation for Other Applications
Get Access of This Report: https://www.factmr.com/checkout/4426
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the global Cardiac Ablation Technologies Market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032.
The study reveals essential insights by Technology (Radiofrequency, Ultrasound, Cryoablation, Microwave, Laser Cardiac Ablation Technology), by Application (Atrial Fibrillation, Ventricular Tachycardia), by Region – Global Forecast 2022-2032.
Explore Fact.MR’s Coverage on the Healthcare Domain-
Amniocentesis Needle Market – Demand for the amniocentesis needles is expected to gain momentum attributed to growing need for removing excessive amniotic fluid from around the baby. Excessive amniotic fluid during pregnancy leads to increasing risks of complication.
Prefilled Syringes Market – Prefilled Syringes Market By Function Type (Single Chambered Prefilled Syringes, Dual/Multi Chambered Prefilled Syringes), By Technology Type (Conventional Prefilled Syringes, Safety Prefilled Syringes), By Distribution Channel, By Material Type – Forecast 2021-2031
Actigraphy Sensors & PSG Devices Market – The Fitbit Care platform features a wide range of devices including wearables and self-tracking devices that continuously track sleep-related activities and other personalized digital interventions for specific disease management.
Lithotripsy Devices Market – Lithotripsy Devices Market Analysis by Product Type (Extracorporeal Shock Wave, Intracorporeal, Laser Lithotripsy Devices), by Application (Kidney Stones, Ureteral Stones, Pancreatic Stones), by End User, by Region – Global Insights 2021-2031
Prostate Cancer Diagnostics Market – Prostate Cancer Diagnostics Market By Test Type (PSA, PCA3, CTC & Immunohistochemistry Prostate Cancer Diagnostic Test), By End User (Prostate Cancer Diagnostics in Hospitals, Prostate Cancer Diagnostics in Cancer Research Institutes)- Global Market insights 2021 to 2031
Urodynamic Devices Market – The primary objective of an urodynamic test is understanding disorders/problems occurring in lower urinary tract by duplication of symptoms. Urodynamic study also help in determination of the causes of bladder dysfunction, formulating an appropriate course for the treatment.
Gas Chromatography Market – Gas chromatography has been witnessing a rise in adoption among various industrial sectors such as food & beverage, agriculture, oil & gas, and healthcare. GC is also being used in environmental agencies, research organizations, clinical toxicology, and academic institutes.
About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
Email: sales@factmr.com
Tel: +1 (628) 251-158